A Low-Cost Biological Agglutination Assay for Medical Diagnostic Applications
暂无分享,去创建一个
Paul S. Freemont | Guy-Bart Stan | Hung-En Lai | Nicolas Kylilis | Karen M. Polizzi | Pinpunya Riangrungroj | Valencio Salema | Luis Ángel Fernández | G. Stan | P. Freemont | K. Polizzi | Pinpunya Riangrungroj | H. Lai | V. Salema | L. A. Fernández | Nicolas Kylilis
[1] Ric,et al. CARDIAC TROPONIN T LEVELS FOR RISK STRATIFICATION IN ACUTE MYOCARDIAL ISCHEMIA , 2000 .
[2] V. Salema,et al. Characterization of nanobodies binding human fibrinogen selected by E. coli display. , 2016, Journal of biotechnology.
[3] S. Muyldermans,et al. Surface display of a single-domain antibody library on Gram-positive bacteria , 2012, Cellular and Molecular Life Sciences.
[4] J. Crowley,et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. , 2004, The New England journal of medicine.
[5] Weiling Fu,et al. Quantitative Determination of Fibrinogen of Patients with Coronary Heart Diseases through Piezoelectric Agglutination Sensor , 2010, Sensors.
[6] A. Bobylev,et al. A kinetic model of the agglutination process. , 1992, Mathematical biosciences.
[7] S. Belkin,et al. Where microbiology meets microengineering: design and applications of reporter bacteria , 2010, Nature Reviews Microbiology.
[8] L. Looger,et al. Computational design of receptor and sensor proteins with novel functions , 2003, Nature.
[9] J. L. Ortega-Vinuesa,et al. A review of factors affecting the performances of latex agglutination tests , 2001, Journal of biomaterials science. Polymer edition.
[10] Stefan Dübel,et al. Targeting Recombinant Antibodies to the Surface of Escherichia coli: Fusion to a Peptidoglycan Associated Lipoprotein , 1991, Bio/Technology.
[11] J. Horswell,et al. Use of biosensors to screen urine samples for potentially toxic chemicals. , 2003, Journal of analytical toxicology.
[12] Paul S. Freemont,et al. Engineering Microbial Biosensors , 2013 .
[13] Kendrick B. Turner,et al. Hydroxylated polychlorinated biphenyl detection based on a genetically engineered bioluminescent whole-cell sensing system. , 2007, Analytical chemistry.
[14] Sonja Billerbeck,et al. A modular yeast biosensor for low-cost point-of-care pathogen detection , 2017, Science Advances.
[15] Richard J. R. Kelwick,et al. A protease-based biosensor for the detection of schistosome cercariae , 2016, Scientific Reports.
[16] Franck Molina,et al. Detection of pathological biomarkers in human clinical samples via amplifying genetic switches and logic gates , 2015, Science Translational Medicine.
[17] B. de Geus,et al. Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama. , 2000, Journal of immunological methods.
[18] S. S. Olmsted,et al. Requirements for high impact diagnostics in the developing world , 2006, Nature.
[19] Ming Chen,et al. Quantitative Determination of Fibrinogen of Patients with Coronary Heart Diseases through Piezoelectric Agglutination Sensor , 2010, Sensors.
[20] F. Harrell,et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. , 1996, The New England journal of medicine.
[21] G. Bodelón,et al. Selection of Single Domain Antibodies from Immune Libraries Displayed on the Surface of E. coli Cells with Two β-Domains of Opposite Topologies , 2013, PloS one.
[22] M. Leinonen,et al. Latex agglutination test for screening of Haemophilus influenzae type b carriers , 1987, Journal of clinical microbiology.
[23] S. Campuzano,et al. Disposable amperometric magnetoimmunosensors using nanobodies as biorecognition element. Determination of fibrinogen in plasma. , 2014, Biosensors & bioelectronics.
[24] S. Thompson,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.
[25] M. Assicot,et al. High serum procalcitonin concentrations in patients with sepsis and infection , 1993, The Lancet.
[26] G. Georgiou,et al. Antibody affinity maturation using bacterial surface display. , 1998, Protein engineering.
[27] H. de Haard,et al. Properties, production, and applications of camelid single-domain antibody fragments , 2007, Applied Microbiology and Biotechnology.
[28] G. Georgiou,et al. Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[29] Aldo Roda,et al. SENSITIVE DETERMINATION OF URINARY MERCURY(II) BY A BIOLUMINESCENT TRANSGENIC BACTERIA-BASED BIOSENSOR , 2001 .
[30] M. Cowie. National Institute for Health and Care Excellence. , 2015, European heart journal.
[31] R. Roovers,et al. High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display , 2016, mAbs.
[32] V. Salema,et al. Escherichia coli surface display for the selection of nanobodies , 2017, Microbial biotechnology.
[33] Kelly A. Schwarz,et al. Modular Extracellular Sensor Architecture for Engineering Mammalian Cell-based Devices , 2014, ACS synthetic biology.
[34] M. Leinonen,et al. The latex agglutination test for the diagnosis of meningococcal and haemophilus influenzae meningitis. , 1977, Scandinavian journal of infectious diseases.
[35] G. Lowe,et al. Plasma fibrinogen , 2004, Annals of clinical biochemistry.
[36] Douglas K. Martin,et al. Top ten biotechnologies for improving health in developing countries , 2002, Nature Genetics.
[37] M. Cavallari. Rapid and Direct VHH and Target Identification by Staphylococcal Surface Display Libraries , 2017, International journal of molecular sciences.
[38] Serge Muyldermans,et al. Nanobodies: natural single-domain antibodies. , 2013, Annual review of biochemistry.
[39] Anil Wipat,et al. Microbial synthetic biology , 2013 .
[40] C. Borrebaeck,et al. Antibodies in diagnostics - from immunoassays to protein chips. , 2000, Immunology today.
[41] Christopher A. Voigt,et al. Automated Design of Synthetic Ribosome Binding Sites to Precisely Control Protein Expression , 2009, Nature Biotechnology.
[42] J. D. den Dunnen,et al. Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation. , 2006, Biochimica et biophysica acta.
[43] Xinbin Chen,et al. Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes , 2004, Oncogene.
[44] Jamshid Tanha,et al. Selection by phage display of llama conventional V(H) fragments with heavy chain antibody V(H)H properties. , 2002, Journal of immunological methods.
[45] Cleo Kontoravdi,et al. Whole‐cell Escherichia coli lactate biosensor for monitoring mammalian cell cultures during biopharmaceutical production , 2017, Biotechnology and bioengineering.
[46] Chad A. Mirkin,et al. Drivers of biodiagnostic development , 2009, Nature.